Related Sciences

We are a data science-driven drug discovery studio

[Related Sciences @RelatedSciences]

Illustrative insight from the Related Sciences Facets data platform. Facets integrates 50+ public and private datasets to enable very unique analyses and predictive AI models to track hidden trends in biotech R&D.

[Adam Kolom @AdamKSay]

Crazy—we took a quick look at our platform data to see if it supported how it "feels" out there. 2024 is on trend for the lowest programs against "new drug targets" in ~30 years. This kind of risk aversion very bad for future patients, especially with so much strong new omics-driven evidence and broadly rising drugability.

[Related Sciences @RelatedSciences]

1,000s of new well-evidenced targets for 1,000s of untreated diseases, now enabled by decades of work on 15+ modalities and advanced new drug discovery techniques and AI. It's a great time to be in the drug creation business.

[Related Sciences @RelatedSciences]

RT @AdamKSay: Proud to announce the expansion and 2030 extension of our global drug discovery partnership with Evotec, which oversees >15 p…